Rational Nanomaterial Design for Ferroptosis Modulation: Bidirectional Therapeutic Strategies in Cancer and Beyond
ACS Nano · 2026
DOI: 10.1021/acsnano.6c10760 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Nano, 2026. Verfasst von Zhongqiang Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu610065, China. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms, Nanostructures, Antineoplastic Agents. Die Arbeit nennt 302 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Funds for Central Universities.
Abstract (Originalsprache)
Ferroptosis, a unique form of regulated, iron-dependent cell death, has emerged as a therapeutic mechanism for a range of diseases, including cancer, neurodegeneration, metabolic disorders, and organ injuries. However, the clinical translation of small-molecule ferroptosis modulators remains limited due to poor specificity, pharmacokinetic instability, and insufficient targeting capability. In contrast, nanomaterials offer a highly tunable and multifunctional platform for ferroptosis modulation, enabling precise delivery, spatiotemporal control, and synergistic therapeutic effects. This review presents a comprehensive synthesis of nanomaterial-based strategies for ferroptosis modulation, emphasizing both induction in cancer therapy and inhibition in non-cancer diseases. We first summarize the molecular mechanisms governing ferroptosis and rational design strategies for nanomaterials targeting ferroptosis-related pathways. We then discuss recent advances in nanomaterial-mediated ferroptosis induction for cancer therapy, and their application of ferroptosis inhibition for treating non-cancer diseases, including inflammatory organ injuries, neurological disorders, and metabolic degeneration. By systematically linking nanomaterial molecular and structural design with ferroptosis regulation mechanisms, this review highlights the dual regulatory role of nanomaterials in both inducing and inhibiting ferroptosis and provides design guidelines for the rational development of ferroptosis-targeting nanomedicines for precision therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu610065, China.
- Department of anesthesiology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu610072, China.
- Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu610031, China.
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu610041, China.
- Med-X Center for Materials, Sichuan University, Chengdu610041, China.
ORCID-Profile: Zhongqiang Zhu, Ling Jiang, Xingyu Chen, Hong Chen, Jianshu Li
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Funds for Central Universities
- State Key Laboratory of Advanced Polymer Materials
Zitieren
APA
Zhu, Z., Jiang, L., Sun, T., Chen, X., Chen, H., & Li, J. (2026). Rational Nanomaterial Design for Ferroptosis Modulation: Bidirectional Therapeutic Strategies in Cancer and Beyond. ACS Nano. https://doi.org/10.1021/acsnano.6c10760
Vancouver
Zhu Z, Jiang L, Sun T, Chen X, Chen H, Li J. Rational Nanomaterial Design for Ferroptosis Modulation: Bidirectional Therapeutic Strategies in Cancer and Beyond. ACS Nano. 2026. doi:10.1021/acsnano.6c10760
BibTeX
@article{Zhu2026,
author = {Zhu, Zhongqiang and Jiang, Ling and Sun, Tong and Chen, Xingyu and Chen, Hong and Li, Jianshu},
title = {Rational Nanomaterial Design for Ferroptosis Modulation: Bidirectional Therapeutic Strategies in Cancer and Beyond},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c10760}
}
EUVIMED